DGX
Price
$168.55
Change
-$3.35 (-1.95%)
Updated
Jul 25 closing price
Capitalization
14.74B
93 days until earnings call
DSRLF
Price
$107.68
Change
-$0.98 (-0.90%)
Updated
Jun 20 closing price
Capitalization
5.99B
Interact to see
Advertisement

DGX vs DSRLF

Header iconDGX vs DSRLF Comparison
Open Charts DGX vs DSRLFBanner chart's image
Quest Diagnostics
Price$168.55
Change-$3.35 (-1.95%)
Volume$1.88M
Capitalization14.74B
Diasorin S.R.L
Price$107.68
Change-$0.98 (-0.90%)
Volume$170
Capitalization5.99B
DGX vs DSRLF Comparison Chart in %
Loading...
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DGX vs. DSRLF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGX is a Hold and DSRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (DGX: $168.55 vs. DSRLF: $107.68)
Brand notoriety: DGX and DSRLF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DGX: 172% vs. DSRLF: 58%
Market capitalization -- DGX: $14.74B vs. DSRLF: $5.99B
DGX [@Medical Specialties] is valued at $14.74B. DSRLF’s [@Medical Specialties] market capitalization is $5.99B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DGX’s FA Score shows that 2 FA rating(s) are green whileDSRLF’s FA Score has 1 green FA rating(s).

  • DGX’s FA Score: 2 green, 3 red.
  • DSRLF’s FA Score: 1 green, 4 red.
According to our system of comparison, DGX is a better buy in the long-term than DSRLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DGX’s TA Score shows that 6 TA indicator(s) are bullish while DSRLF’s TA Score has 3 bullish TA indicator(s).

  • DGX’s TA Score: 6 bullish, 4 bearish.
  • DSRLF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, DGX is a better buy in the short-term than DSRLF.

Price Growth

DGX (@Medical Specialties) experienced а +0.98% price change this week, while DSRLF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

DGX is expected to report earnings on Oct 28, 2025.

Industries' Descriptions

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DGX($14.7B) has a higher market cap than DSRLF($5.99B). DSRLF has higher P/E ratio than DGX: DSRLF (27.32) vs DGX (17.99). DGX YTD gains are higher at: 13.335 vs. DSRLF (0.773). DGX has higher annual earnings (EBITDA): 1.73B vs. DSRLF (286M). DGX has more cash in the bank: 686M vs. DSRLF (382M). DSRLF has less debt than DGX: DSRLF (1.37B) vs DGX (5.5B). DGX has higher revenues than DSRLF: DGX (9.25B) vs DSRLF (1.25B).
DGXDSRLFDGX / DSRLF
Capitalization14.7B5.99B245%
EBITDA1.73B286M606%
Gain YTD13.3350.7731,726%
P/E Ratio17.9927.3266%
Revenue9.25B1.25B739%
Total Cash686M382M180%
Total Debt5.5B1.37B401%
FUNDAMENTALS RATINGS
DGX vs DSRLF: Fundamental Ratings
DGX
DSRLF
OUTLOOK RATING
1..100
5749
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
29100
SMR RATING
1..100
5762
PRICE GROWTH RATING
1..100
5456
P/E GROWTH RATING
1..100
4974
SEASONALITY SCORE
1..100
505

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DGX's Valuation (9) in the Servicestothe Health Industry industry is in the same range as DSRLF (13) in the null industry. This means that DGX’s stock grew similarly to DSRLF’s over the last 12 months.

DGX's Profit vs Risk Rating (29) in the Servicestothe Health Industry industry is significantly better than the same rating for DSRLF (100) in the null industry. This means that DGX’s stock grew significantly faster than DSRLF’s over the last 12 months.

DGX's SMR Rating (57) in the Servicestothe Health Industry industry is in the same range as DSRLF (62) in the null industry. This means that DGX’s stock grew similarly to DSRLF’s over the last 12 months.

DGX's Price Growth Rating (54) in the Servicestothe Health Industry industry is in the same range as DSRLF (56) in the null industry. This means that DGX’s stock grew similarly to DSRLF’s over the last 12 months.

DGX's P/E Growth Rating (49) in the Servicestothe Health Industry industry is in the same range as DSRLF (74) in the null industry. This means that DGX’s stock grew similarly to DSRLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DGXDSRLF
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
37%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
46%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
43%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
34%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 2 days ago
31%
Advances
ODDS (%)
Bullish Trend 10 days ago
63%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
46%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
35%
Bearish Trend 2 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UCYB60.460.41
+0.69%
ProShares Ultra Nasdaq Cybersecurity
FBT166.120.27
+0.16%
First Trust NYSE Arca Biotech ETF
ARGD21.080.03
+0.14%
Argo Group US
PPIE27.090.02
+0.07%
Putnam PanAgora ESG Intl Eq ETF
KGRN28.59-0.06
-0.22%
KraneShares MSCI China Clean Tech ETF

DGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DGX has been loosely correlated with LH. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if DGX jumps, then LH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGX
1D Price
Change %
DGX100%
-1.95%
LH - DGX
66%
Loosely correlated
-1.02%
SYK - DGX
41%
Loosely correlated
+1.73%
MEDP - DGX
41%
Loosely correlated
-1.80%
STE - DGX
40%
Loosely correlated
+1.41%
IQV - DGX
40%
Loosely correlated
+2.54%
More

DSRLF and

Correlation & Price change

A.I.dvisor tells us that DSRLF and PRE have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DSRLF and PRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSRLF
1D Price
Change %
DSRLF100%
N/A
PRE - DSRLF
26%
Poorly correlated
N/A
BJDX - DSRLF
22%
Poorly correlated
-0.64%
DGX - DSRLF
20%
Poorly correlated
-1.95%
DHR - DSRLF
20%
Poorly correlated
+1.32%
ESLOF - DSRLF
10%
Poorly correlated
+1.21%
More